A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/496 (2006.01) A61P 25/00 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2654791
Disclosed are methods of reducing amyloid-.beta. peptide levels in a subject. The method involves administering to the subject a therapeutically effective amount of a bisdioxopiperazine or a pharmaceutically acceptable salt thereof to reduce .beta.-amyloid peptide levels.
La présente invention concerne des procédés de réduction des taux de peptide amyloïde b chez un sujet. Le procédé met en AEuvre l'administration au sujet d'une quantité thérapeutiquement efficace d'une bisdioxopipérazine ou un sel pharmaceutiquement acceptable de celle-ci pour réduire les taux de peptide amyloïde b.
Greig Nigel H.
Hellmann Kurt
Department Of Health And Human Services The Government Of The United States Of America As Represented By
Gowling Lafleur Henderson Llp
Hellmann Kurt
LandOfFree
A method of reducing amyloid-beta peptide levels using a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method of reducing amyloid-beta peptide levels using a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of reducing amyloid-beta peptide levels using a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1453299